Effects of Magnesium Oil Application on the Muscle Contractile Properties

Magnesium Clinical Trial

— MG-MCP2022  

Official title:

Effects of Magnesium Oil Application on the Muscle Contractile Properties

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05339308
• Other study ID #: MG-MCP2022
• Status: Completed
• Phase: N/A
• Start date: May 1, 2022
• Est. completion date: September 1, 2022

Study information

• Verified date: October 2022
• Source: University of Ljubljana
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties.

Description:

Aim: This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties (SMcp). Design: Randomized controlled study Participants: For this purpose, investigators will recruit 40 recreationally active and healthy adults of both sexes (18-35 years of age). Methods: The experimental leg (EXP) will receive the 10 sprays of magnesium oil (20 mg per spray) that will be topically applied to the skin covering the knee extensor muscles, whereas the control leg (CON) will receive 10 sprays of natural mineral-free oil. The vastus lateralis SMcp will be measured by using a tensiomyography (TMG) device before application (PRE) and after 10 (POST10), 20 (POST20), 30 (POST30), 40 (POST40), and 50 (POST50) minutes of application onset, respectively.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: September 1, 2022
• Est. primary completion date: August 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• healthy, recreationally active adults, no history of neuromuscular and musculoskeletal diseases

Exclusion Criteria:

• if some of the criteria are not met

Related Conditions & MeSH terms

• Magnesium

Intervention

Other:
• Magnesium oil (BetterYou) dermal application
10 sprays (200 mg) of magnesium oil (BetterYou) will be applied to skin covering knee extensor muscles. The magnesium oil will be applied only once
• Placebo Control
Natural mineral-free oil (10 sprays) will be applied as the control condition. This will be done only once

Locations

Country	Name	City	State
Czechia	Masaryk University	Brno
Slovenia	Faculty of Sport	Ljubljana

Sponsors (2)

Lead Sponsor	Collaborator
University of Ljubljana	Masaryk University

Countries where clinical trial is conducted

Czechia,  Slovenia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Skeletal Muscle Contractile Properties	Skeletal muscle contractile properties will be measured by using tensiomyography device	75 minutes